Impact of different biochemical markers in serum of patients with benign and malignant liver diseases-Reference-Cited by-同舟云学术

Impact of different biochemical markers in serum of patients with benign and malignant liver diseases

Published:2011-01 Issue:1 Volume:2 Page:49-55
ISSN:2090-1232
Container-title:Journal of Advanced Research
language:en
Short-container-title:Journal of Advanced Research

Author:

Zakhary Nadia I.,El-Merzabani Mahmoud M.,El-Sawi Nagwa M.,Saleh Saleh M.,Moneer Manar M.,Mohamad Ragaa H.

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference40 articles.

1. Mokhtar N, Gouda I, Adel I. Cancer pathology registry 2003–2004 and time trend analysis. Department of Pathology, National Cancer Institute, Cairo University; 2007.

2. AASLD practice guidelines: chronic hepatitis B;Lok;Hepatology,2001

3. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance;Sangiovanni;Gastroenterology,2004

4. Gene expression in HCV-associated hepatocellular carcinoma – upregulation of a gene encoding a protein related to the ubiquitin-conjugating enzyme;El Nady;Liver Int,2003

5. Epidemiology of primary liver cancer;Bosch;Semin Liver Dis,1999

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor necrosis factor-alpha and alpha-fetoprotein as biomarkers for diagnosis and follow-up of hepatocellular carcinoma before and after interventional therapy;The Egyptian Journal of Internal Medicine;2019-12

2. A systematic review and meta-analysis of evaluation of serum interleukin 8 levels in hepatocellular carcinoma;Clinical and Experimental Hepatology;2019

3. Evaluation of serum interleukin-10 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis;Clinical and Experimental Hepatology;2018

4. Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients;ISRN Hepatology;2013-09-15